Artyom Kachanov

Artyom Kachanov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Research Subjects


Artyom Kachanov has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Parodi

    Scientific Center for Translational Medicine, Sirius University of Science and Technology, 354340 Sirius, Russia

    1 shared publication
  • Alexandra Yudaeva

    Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia

    1 shared publication
  • Anastasiya Kostyusheva

    Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, First Moscow State Medical University (Sechenov University), 119991 Moscow, Russia

    1 shared publication
  • Andrey A. Zamyatnin

    Belozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119992 Moscow, Russia

    1 shared publication
  • Andrey Tikhonov

    Laboratory of Experimental Therapy of Infectious Diseases, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University

    1 shared publication
  • Dmitry Kostyushev

    Laboratory of Genetic Technologies, Martsinovsky Institute of Medical Parasitology, Tropical and Vector-Borne Diseases, Sechenov University, Moscow 119435, Russia

    1 shared publication

Latest Publications

  • Open Access

    Biomimetic Nanoparticles for Basic Drug Delivery

    by Andrey Tikhonov, Artyom Kachanov, Alexandra Yudaeva, Oleg Danilik, Natalia Ponomareva, Ivan Karandashov, Anastasiya Kostyusheva, Andrey A. Zamyatnin, Alessandro Parodi, Vladimir Chulanov, et al.

    Biomimetic nanoparticles (BMNPs) are innovative nanovehicles that replicate the properties of naturally occurring extracellular vesicles, facilitating highly efficient drug delivery across biological barriers to target organs and tissues while ensuring maximal biocompatibility and minimal-to-no toxicity. BMNPs can be utilized for the delivery of therapeutic payloads and for imparting novel properties to other nanotechnologies based on organic and inorganic materials. The application of specifically modified biological membranes for coating organic and inorganic nanoparticles has the potential to enhance their therapeutic efficacy and biocompatibility, presenting a promising pathway for the advancement of drug delivery technologies. This manuscript is grounded in the fundamentals of biomimetic technologies, offering a comprehensive overview and analytical perspective on the preparation and functionalization of BMNPs, which include cell membrane-coated nanoparticles (CMCNPs), artificial cell-derived vesicles (ACDVs), and fully synthetic vesicles (fSVs). This review examines both “top-down” and “bottom-up” approaches for nanoparticle preparation, with a particular focus on techniques such as cell membrane coating, cargo loading, and microfluidic fabrication. Additionally, it addresses the technological challenges and potential solutions associated with the large-scale production and clinical application of BMNPs and related technologies.